LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas

MLA

Jun Su, et al. “LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas.” Frontiers in Oncology, vol. 9, Oct. 2019. EBSCOhost, https://doi.org/10.3389/fonc.2019.01083.

APA

Jun Su, Qianquan Ma, Wenyong Long, Hailin Tang, Changwu Wu, Mei Luo, Xiangyu Wang, Kai Xiao, Yang Li, Qun Xiao, Chi Zhang, Haoyu Li, & Qing Liu. (2019). LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas. Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.01083

Chicago

Jun Su, Qianquan Ma, Wenyong Long, Hailin Tang, Changwu Wu, Mei Luo, Xiangyu Wang, et al. 2019. “LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas.” Frontiers in Oncology 9 (October). doi:10.3389/fonc.2019.01083.